These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
924 related articles for article (PubMed ID: 30509194)
1. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M; BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194 [TBL] [Abstract][Full Text] [Related]
2. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015. Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M; BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203 [TBL] [Abstract][Full Text] [Related]
3. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ; BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671 [TBL] [Abstract][Full Text] [Related]
4. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area. Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M; BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275 [TBL] [Abstract][Full Text] [Related]
5. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe. Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689 [TBL] [Abstract][Full Text] [Related]
6. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016. Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M; BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019. Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018. Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance in Hernando Rovirola C; Spiteri G; Sabidó M; Montoliu A; Gonzalez V; Casabona J; Cole MJ; Noori T; Unemo M Sex Transm Infect; 2020 May; 96(3):204-210. PubMed ID: 32019895 [TBL] [Abstract][Full Text] [Related]
10. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503 [TBL] [Abstract][Full Text] [Related]
11. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance. Cole MJ; Spiteri G; Jacobsson S; Pitt R; Grigorjev V; Unemo M; BMC Infect Dis; 2015 Aug; 15():321. PubMed ID: 26259560 [TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269 [TBL] [Abstract][Full Text] [Related]
13. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012. Kubanova A; Kubanov A; Frigo N; Solomka V; Semina V; Vorobyev D; Khairullin R; Unemo M BMC Infect Dis; 2014 Jun; 14():342. PubMed ID: 24947981 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility in Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009). Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633 [TBL] [Abstract][Full Text] [Related]
16. The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)--a sentinel approach in the European Union (EU)/European Economic Area (EEA). Spiteri G; Cole M; Unemo M; Hoffmann S; Ison C; van de Laar M Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv16-8. PubMed ID: 24243874 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study. Golparian D; Cole MJ; Sánchez-Busó L; Day M; Jacobsson S; Uthayakumaran T; Abad R; Bercot B; Caugant DA; Heuer D; Jansen K; Pleininger S; Stefanelli P; Aanensen DM; Bluemel B; Unemo M; Lancet Microbe; 2024 May; 5(5):e478-e488. PubMed ID: 38614111 [TBL] [Abstract][Full Text] [Related]
18. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16. Bazzo ML; Golfetto L; Gaspar PC; Pires AF; Ramos MC; Franchini M; Ferreira WA; Unemo M; Benzaken AS; J Antimicrob Chemother; 2018 Jul; 73(7):1854-1861. PubMed ID: 29635367 [TBL] [Abstract][Full Text] [Related]
19. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015. Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519 [TBL] [Abstract][Full Text] [Related]
20. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019. Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]